Synonyms:Ezetimibe, 163222-33-1, Zetia, Ezetrol, Ezedoc, Sch 58235, (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one, SCH58235, SCH-58235, Ezetimibe (Zetia), (3R,4S)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one, EOR26LQQ24, DTXSID1044223, CHEBI:49040, MK0653, NSC-758923, (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone, 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone, DTXCID9024223, Zient, C24H21F2NO3, (-)-Sch 58235, (3~{R},4~{S})-1-(4-fluorophenyl)-3-[(3~{S})-3-(4-fluorophenyl)-3-oxidanyl-propyl]-4-(4-hydroxyphenyl)azetidin-2-one, 2-Azetidinone, 1-(4-fluorophenyl)-3-((3S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-, (3R,4S)-, 2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-, SMR000466334, CAS-163222-33-1, Zetia (TN), UNII-EOR26LQQ24, ezetimiba, ezetimibum, Ezetimibe [USAN:INN:BAN], Ezetimibe), MFCD00937872, HSDB 7737, ezetimibe anhydrate, Ezetimibe- Bio-X, NCGC00095134-01, Ezetimibe [USAN], MK-0653, EZETIMIBE [INN], EZETIMIBE [JAN], EZETIMIBE [MI], EZETIMIBE [HSDB], EZETIMIBE [VANDF], EZETIMIBE [MART.], EZETIMIBE [USP-RS], EZETIMIBE [WHO-DD], SCHEMBL2871, CHEMBL1138, Ezetimibe (JAN/USP/INN), MLS000759443, MLS001424125, MLS006011921, GTPL6816, EZETIMIBE [ORANGE BOOK], Ezetimibe, >=98% (HPLC), ROSZET COMPONENT EZETIMIBE, EX-A795, EZETIMIBE [USP MONOGRAPH], VYTORIN COMPONENT EZETIMIBE, HMS2051K16, HMS2236A04, HMS3715D06, NEXLIZET COMPONENT EZETIMIBE, (3R,4S)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone, ACT03511, EZETIMIBE COMPONENT OF ROSZET, Tox21_111443, BDBM50371521, s1655, STK640490, EZETIMIBE COMPONENT OF VYTORIN, AKOS005572111, EZETIMIBE COMPONENT OF NEXLIZET, Tox21_111443_1, AC-1057, AM84560, CCG-100884, DB00973, KS-1170, NC00134, NSC 758923, NCGC00263575-01, NCGC00263575-07, (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)azetidin-2-one, 2-Azetidinone, 1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-, (3R-(3alpha(S*),4beta))-, BE164439, HY-17376, E1449, D01966, EN300-122361, AB00639916-06, AB00639916-08, AB00639916_09, AR-270/43507897, Q417997, 3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one, BRD-K42260897-001-09-2, Z1541759501, (3R,4S)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-, Ezetimibe, United States Pharmacopeia (USP) Reference Standard, Ezetimibe, Pharmaceutical Secondary Standard; Certified Reference Material, (3R,4S)-1-(4-fluorophenyl)-3-[(3 S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one, (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)- 3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one, (3R,4S)-1-(4-Fluorophenyl)-3-[(S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-azetidin-2-one, 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone, 2-AZETIDINONE, 1-(4-FLUOROPHENYL)-3-(3-(4-FLUOROPHENYL)-3-HYDROXYPROPYL)-4-(4-HYDROXYPHENYL)-, (3R-(3.ALPHA.(S*),4.BETA.))-, H56
Pubchem:PUBCHEM:150311
Id:cf1b377c-a8e6-5b7e-8985-8bec283791d8
Description:nan
